Information:
Fel:
ID
16300
Beskrivning
Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line; ODM derived from: https://clinicaltrials.gov/show/NCT00191854
Länk
https://clinicaltrials.gov/show/NCT00191854
Nyckelord
Versioner (1)
- 2016-07-10 2016-07-10 -
Uppladdad den
10 juli 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00191854
Eligibility Breast Cancer NCT00191854
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00191854
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
woman with diagnosis of breast cancer
Item
female patients with histological or cytological proven diagnosis of breast cancer
boolean
C0079399 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
Tumor Stage
Item
stage iv disease
boolean
C1300072 (UMLS CUI [1])
ECOG
Item
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
boolean
C1520224 (UMLS CUI [1])
Previous anthracycline based regimens
Item
patients had to have previously received anthracycline based regimens as a adjuvant therapy or neo-adjuvant chemotherapy and then progressed and developed metastatic disease
boolean
C0278941 (UMLS CUI [1])
C2939420 (UMLS CUI [2])
C2939420 (UMLS CUI [2])
organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
prior chemotherapy for metastatic disease
Item
prior chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,2])
whole pelvis radiation
Item
previous radiation therapy is allowed but must not have included whole pelvis radiation
boolean
C1522449 (UMLS CUI [1,1])
C3827467 (UMLS CUI [1,2])
C3827467 (UMLS CUI [1,2])
brain metastasis or serious concomitant disorders
Item
known or suspected brain metastasis. serious concomitant disorders that would compromise the safety of the patient or compromise the patient's ability to complete the study, at the discretion of the investigator
boolean
C0220650 (UMLS CUI [1])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
concurrent tumor therapy
Item
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy and immunotherapy (including trastuzumab (herceptin))
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
peripheral neuropathy, neurological or mental disorder
Item
peripheral neuropathy of common toxicity criteria (ctc) grade greater than 1. history of significant neurological or mental disorder, including seizures or dementia
boolean
C0031117 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0027765 (UMLS CUI [2])
C0004936 (UMLS CUI [3])